nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—PTGS2—Risedronate—osteoporosis	0.141	0.254	CbGbCtD
Acetylsalicylic acid—ALB—Estropipate—osteoporosis	0.0674	0.121	CbGbCtD
Acetylsalicylic acid—SLC22A6—Conjugated Estrogens—osteoporosis	0.0375	0.0674	CbGbCtD
Acetylsalicylic acid—CYP2C9—Estropipate—osteoporosis	0.0364	0.0654	CbGbCtD
Acetylsalicylic acid—CYP2C8—Raloxifene—osteoporosis	0.0348	0.0626	CbGbCtD
Acetylsalicylic acid—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0336	0.0604	CbGbCtD
Acetylsalicylic acid—ALB—Estradiol—osteoporosis	0.028	0.0504	CbGbCtD
Acetylsalicylic acid—CYP2C8—Cholecalciferol—osteoporosis	0.0268	0.0483	CbGbCtD
Acetylsalicylic acid—ABCB1—Ethinyl Estradiol—osteoporosis	0.0227	0.0409	CbGbCtD
Acetylsalicylic acid—CYP2C19—Cholecalciferol—osteoporosis	0.0225	0.0405	CbGbCtD
Acetylsalicylic acid—CYP2C8—Estradiol—osteoporosis	0.0216	0.0389	CbGbCtD
Acetylsalicylic acid—CYP2C9—Cholecalciferol—osteoporosis	0.0187	0.0337	CbGbCtD
Acetylsalicylic acid—CYP2C19—Estradiol—osteoporosis	0.0182	0.0327	CbGbCtD
Acetylsalicylic acid—ABCB1—Conjugated Estrogens—osteoporosis	0.0167	0.03	CbGbCtD
Acetylsalicylic acid—CYP2C9—Estradiol—osteoporosis	0.0151	0.0272	CbGbCtD
Acetylsalicylic acid—TP53—skull—osteoporosis	0.0148	0.289	CbGeAlD
Acetylsalicylic acid—ABCB1—Estradiol—osteoporosis	0.0146	0.0264	CbGbCtD
Acetylsalicylic acid—TP53—manual digit—osteoporosis	0.0107	0.209	CbGeAlD
Acetylsalicylic acid—PTGS2—periosteum—osteoporosis	0.00348	0.0678	CbGeAlD
Acetylsalicylic acid—TP53—uterus—osteoporosis	0.00247	0.0482	CbGeAlD
Acetylsalicylic acid—NFKBIA—uterus—osteoporosis	0.00243	0.0474	CbGeAlD
Acetylsalicylic acid—HSPA5—uterus—osteoporosis	0.00238	0.0464	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—osteoporosis	0.00209	0.0409	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—osteoporosis	0.00206	0.0402	CbGeAlD
Acetylsalicylic acid—RPS6KA3—uterus—osteoporosis	0.00202	0.0395	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—osteoporosis	0.00202	0.0394	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—osteoporosis	0.00172	0.0335	CbGeAlD
Acetylsalicylic acid—EDNRA—uterus—osteoporosis	0.00165	0.0321	CbGeAlD
Acetylsalicylic acid—IKBKB—uterus—osteoporosis	0.00149	0.0292	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Estradiol—osteoporosis	0.00149	0.325	CbGdCrCtD
Acetylsalicylic acid—TP53—Danazol—Ethinyl Estradiol—osteoporosis	0.00118	0.258	CbGdCrCtD
Acetylsalicylic acid—TP53—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00106	0.232	CbGdCrCtD
Acetylsalicylic acid—TP53—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000844	0.185	CbGdCrCtD
Acetylsalicylic acid—Deafness—Estradiol—osteoporosis	0.000579	0.00337	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etidronic acid—osteoporosis	0.000561	0.00327	CcSEcCtD
Acetylsalicylic acid—Dizziness—Calcium Acetate—osteoporosis	0.00056	0.00326	CcSEcCtD
Acetylsalicylic acid—Asthma—Conjugated Estrogens—osteoporosis	0.000559	0.00326	CcSEcCtD
Acetylsalicylic acid—Influenza—Conjugated Estrogens—osteoporosis	0.000559	0.00326	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000552	0.00321	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000549	0.0032	CcSEcCtD
Acetylsalicylic acid—Angioedema—Estropipate—osteoporosis	0.000539	0.00314	CcSEcCtD
Acetylsalicylic acid—Vomiting—Calcium Acetate—osteoporosis	0.000539	0.00314	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Risedronate—osteoporosis	0.000538	0.00313	CcSEcCtD
Acetylsalicylic acid—Purpura—Estradiol—osteoporosis	0.000537	0.00313	CcSEcCtD
Acetylsalicylic acid—Anaemia—Alendronate—osteoporosis	0.000537	0.00312	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Risedronate—osteoporosis	0.000535	0.00312	CcSEcCtD
Acetylsalicylic acid—Angioedema—Alendronate—osteoporosis	0.000531	0.00309	CcSEcCtD
Acetylsalicylic acid—Vertigo—Estropipate—osteoporosis	0.00053	0.00308	CcSEcCtD
Acetylsalicylic acid—Anaemia—Ibandronate—osteoporosis	0.000523	0.00304	CcSEcCtD
Acetylsalicylic acid—Vertigo—Alendronate—osteoporosis	0.000522	0.00304	CcSEcCtD
Acetylsalicylic acid—Angioedema—Ibandronate—osteoporosis	0.000517	0.00301	CcSEcCtD
Acetylsalicylic acid—Vertigo—Raloxifene—osteoporosis	0.000513	0.00299	CcSEcCtD
Acetylsalicylic acid—Syncope—Raloxifene—osteoporosis	0.000512	0.00298	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Pamidronate—osteoporosis	0.000512	0.00298	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Pamidronate—osteoporosis	0.000509	0.00296	CcSEcCtD
Acetylsalicylic acid—Agitation—Calcitriol—osteoporosis	0.000509	0.00296	CcSEcCtD
Acetylsalicylic acid—Vertigo—Ibandronate—osteoporosis	0.000508	0.00296	CcSEcCtD
Acetylsalicylic acid—Nausea—Calcium Acetate—osteoporosis	0.000503	0.00293	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Raloxifene—osteoporosis	0.000502	0.00292	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Estropipate—osteoporosis	0.000502	0.00292	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Risedronate—osteoporosis	0.000499	0.00291	CcSEcCtD
Acetylsalicylic acid—PTGS1—uterus—osteoporosis	0.000497	0.00971	CbGeAlD
Acetylsalicylic acid—Chest pain—Alendronate—osteoporosis	0.000495	0.00288	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Etidronic acid—osteoporosis	0.00049	0.00285	CcSEcCtD
Acetylsalicylic acid—Hypertension—Ibandronate—osteoporosis	0.000488	0.00284	CcSEcCtD
Acetylsalicylic acid—Chest pain—Raloxifene—osteoporosis	0.000486	0.00283	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Raloxifene—osteoporosis	0.000486	0.00283	CcSEcCtD
Acetylsalicylic acid—Chest pain—Ibandronate—osteoporosis	0.000481	0.0028	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Ibandronate—osteoporosis	0.000481	0.0028	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Estropipate—osteoporosis	0.000481	0.0028	CcSEcCtD
Acetylsalicylic acid—Convulsion—Calcitriol—osteoporosis	0.00048	0.00279	CcSEcCtD
Acetylsalicylic acid—Hypertension—Calcitriol—osteoporosis	0.000478	0.00278	CcSEcCtD
Acetylsalicylic acid—PTGS2—uterus—osteoporosis	0.000475	0.00928	CbGeAlD
Acetylsalicylic acid—Flushing—Pamidronate—osteoporosis	0.000472	0.00275	CcSEcCtD
Acetylsalicylic acid—Chest pain—Calcitriol—osteoporosis	0.000471	0.00274	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Ibandronate—osteoporosis	0.000462	0.00269	CcSEcCtD
Acetylsalicylic acid—Shock—Raloxifene—osteoporosis	0.000459	0.00267	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etidronic acid—osteoporosis	0.000458	0.00267	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Raloxifene—osteoporosis	0.000457	0.00266	CcSEcCtD
Acetylsalicylic acid—Shock—Ibandronate—osteoporosis	0.000454	0.00264	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Calcitriol—osteoporosis	0.000452	0.00263	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Raloxifene—osteoporosis	0.000451	0.00262	CcSEcCtD
Acetylsalicylic acid—Influenza—Estradiol—osteoporosis	0.000448	0.00261	CcSEcCtD
Acetylsalicylic acid—Asthma—Estradiol—osteoporosis	0.000448	0.00261	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Ibandronate—osteoporosis	0.000446	0.0026	CcSEcCtD
Acetylsalicylic acid—Nausea—Ergocalciferol—osteoporosis	0.000445	0.00259	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etidronic acid—osteoporosis	0.000442	0.00257	CcSEcCtD
Acetylsalicylic acid—Angioedema—Ethinyl Estradiol—osteoporosis	0.000437	0.00254	CcSEcCtD
Acetylsalicylic acid—Flushing—Zoledronate—osteoporosis	0.000431	0.00251	CcSEcCtD
Acetylsalicylic acid—Anaemia—Risedronate—osteoporosis	0.000431	0.00251	CcSEcCtD
Acetylsalicylic acid—Somnolence—Estropipate—osteoporosis	0.000428	0.00249	CcSEcCtD
Acetylsalicylic acid—Angioedema—Risedronate—osteoporosis	0.000426	0.00248	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Estropipate—osteoporosis	0.000424	0.00247	CcSEcCtD
Acetylsalicylic acid—Vertigo—Risedronate—osteoporosis	0.000419	0.00244	CcSEcCtD
Acetylsalicylic acid—Syncope—Risedronate—osteoporosis	0.000418	0.00243	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Alendronate—osteoporosis	0.000417	0.00243	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Raloxifene—osteoporosis	0.00041	0.00239	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Etidronic acid—osteoporosis	0.00041	0.00239	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Risedronate—osteoporosis	0.00041	0.00238	CcSEcCtD
Acetylsalicylic acid—Anaemia—Pamidronate—osteoporosis	0.00041	0.00238	CcSEcCtD
Acetylsalicylic acid—Agitation—Pamidronate—osteoporosis	0.000407	0.00237	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Ibandronate—osteoporosis	0.000406	0.00236	CcSEcCtD
Acetylsalicylic acid—Angioedema—Pamidronate—osteoporosis	0.000405	0.00236	CcSEcCtD
Acetylsalicylic acid—PTGS2—bone marrow—osteoporosis	0.000403	0.00787	CbGeAlD
Acetylsalicylic acid—Hypertension—Risedronate—osteoporosis	0.000402	0.00234	CcSEcCtD
Acetylsalicylic acid—Somnolence—Calcitriol—osteoporosis	0.000402	0.00234	CcSEcCtD
Acetylsalicylic acid—Syncope—Pamidronate—osteoporosis	0.000397	0.00231	CcSEcCtD
Acetylsalicylic acid—Chest pain—Risedronate—osteoporosis	0.000397	0.00231	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Risedronate—osteoporosis	0.000397	0.00231	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Pamidronate—osteoporosis	0.000397	0.00231	CcSEcCtD
Acetylsalicylic acid—Pruritus—Etidronic acid—osteoporosis	0.000394	0.00229	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Alendronate—osteoporosis	0.000391	0.00227	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Pamidronate—osteoporosis	0.000389	0.00227	CcSEcCtD
Acetylsalicylic acid—Convulsion—Pamidronate—osteoporosis	0.000384	0.00223	CcSEcCtD
Acetylsalicylic acid—Hypertension—Pamidronate—osteoporosis	0.000383	0.00223	CcSEcCtD
Acetylsalicylic acid—Urticaria—Estropipate—osteoporosis	0.000382	0.00223	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Etidronic acid—osteoporosis	0.000381	0.00222	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Ibandronate—osteoporosis	0.00038	0.00221	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Pamidronate—osteoporosis	0.000377	0.0022	CcSEcCtD
Acetylsalicylic acid—Urticaria—Alendronate—osteoporosis	0.000377	0.00219	CcSEcCtD
Acetylsalicylic acid—Shock—Risedronate—osteoporosis	0.000374	0.00218	CcSEcCtD
Acetylsalicylic acid—Anaemia—Zoledronate—osteoporosis	0.000374	0.00218	CcSEcCtD
Acetylsalicylic acid—Agitation—Zoledronate—osteoporosis	0.000372	0.00216	CcSEcCtD
Acetylsalicylic acid—Angioedema—Zoledronate—osteoporosis	0.00037	0.00215	CcSEcCtD
Acetylsalicylic acid—Urticaria—Ibandronate—osteoporosis	0.000367	0.00213	CcSEcCtD
Acetylsalicylic acid—Confusional state—Pamidronate—osteoporosis	0.000365	0.00212	CcSEcCtD
Acetylsalicylic acid—Vertigo—Zoledronate—osteoporosis	0.000364	0.00212	CcSEcCtD
Acetylsalicylic acid—Syncope—Zoledronate—osteoporosis	0.000363	0.00211	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Zoledronate—osteoporosis	0.000362	0.00211	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Pamidronate—osteoporosis	0.000362	0.0021	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Estradiol—osteoporosis	0.00036	0.0021	CcSEcCtD
Acetylsalicylic acid—Urticaria—Calcitriol—osteoporosis	0.000359	0.00209	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Estradiol—osteoporosis	0.000358	0.00209	CcSEcCtD
Acetylsalicylic acid—Angioedema—Conjugated Estrogens—osteoporosis	0.000356	0.00207	CcSEcCtD
Acetylsalicylic acid—Shock—Pamidronate—osteoporosis	0.000356	0.00207	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Zoledronate—osteoporosis	0.000356	0.00207	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Estropipate—osteoporosis	0.000355	0.00206	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Pamidronate—osteoporosis	0.000354	0.00206	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etidronic acid—osteoporosis	0.000354	0.00206	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Pamidronate—osteoporosis	0.000353	0.00205	CcSEcCtD
Acetylsalicylic acid—Rash—Etidronic acid—osteoporosis	0.000351	0.00204	CcSEcCtD
Acetylsalicylic acid—Convulsion—Zoledronate—osteoporosis	0.000351	0.00204	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etidronic acid—osteoporosis	0.00035	0.00204	CcSEcCtD
Acetylsalicylic acid—Vertigo—Conjugated Estrogens—osteoporosis	0.00035	0.00204	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Pamidronate—osteoporosis	0.00035	0.00203	CcSEcCtD
Acetylsalicylic acid—Syncope—Conjugated Estrogens—osteoporosis	0.000349	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypertension—Zoledronate—osteoporosis	0.000349	0.00203	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Alendronate—osteoporosis	0.000349	0.00203	CcSEcCtD
Acetylsalicylic acid—Chest pain—Zoledronate—osteoporosis	0.000345	0.00201	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Zoledronate—osteoporosis	0.000345	0.00201	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000343	0.00199	CcSEcCtD
Acetylsalicylic acid—Pruritus—Estropipate—osteoporosis	0.000341	0.00198	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Ibandronate—osteoporosis	0.00034	0.00198	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Risedronate—osteoporosis	0.000339	0.00197	CcSEcCtD
Acetylsalicylic acid—Convulsion—Conjugated Estrogens—osteoporosis	0.000338	0.00197	CcSEcCtD
Acetylsalicylic acid—Pruritus—Alendronate—osteoporosis	0.000335	0.00195	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Risedronate—osteoporosis	0.000335	0.00195	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Estradiol—osteoporosis	0.000334	0.00194	CcSEcCtD
Acetylsalicylic acid—Confusional state—Zoledronate—osteoporosis	0.000333	0.00194	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Calcitriol—osteoporosis	0.000333	0.00194	CcSEcCtD
Acetylsalicylic acid—Flushing—Estradiol—osteoporosis	0.000333	0.00194	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Conjugated Estrogens—osteoporosis	0.000332	0.00193	CcSEcCtD
Acetylsalicylic acid—Chest pain—Conjugated Estrogens—osteoporosis	0.000332	0.00193	CcSEcCtD
Acetylsalicylic acid—Nausea—Etidronic acid—osteoporosis	0.00033	0.00192	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Zoledronate—osteoporosis	0.00033	0.00192	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Estropipate—osteoporosis	0.000329	0.00192	CcSEcCtD
Acetylsalicylic acid—Pruritus—Ibandronate—osteoporosis	0.000327	0.0019	CcSEcCtD
Acetylsalicylic acid—Shock—Zoledronate—osteoporosis	0.000325	0.00189	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Alendronate—osteoporosis	0.000324	0.00189	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Zoledronate—osteoporosis	0.000323	0.00188	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Pamidronate—osteoporosis	0.000322	0.00188	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Zoledronate—osteoporosis	0.000322	0.00188	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000322	0.00187	CcSEcCtD
Acetylsalicylic acid—Somnolence—Pamidronate—osteoporosis	0.000321	0.00187	CcSEcCtD
Acetylsalicylic acid—Pruritus—Calcitriol—osteoporosis	0.00032	0.00186	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Zoledronate—osteoporosis	0.000319	0.00186	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Raloxifene—osteoporosis	0.000319	0.00186	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Pamidronate—osteoporosis	0.000318	0.00185	CcSEcCtD
Acetylsalicylic acid—Dizziness—Estropipate—osteoporosis	0.000318	0.00185	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000318	0.00185	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Ibandronate—osteoporosis	0.000316	0.00184	CcSEcCtD
Acetylsalicylic acid—Dizziness—Alendronate—osteoporosis	0.000314	0.00182	CcSEcCtD
Acetylsalicylic acid—Shock—Conjugated Estrogens—osteoporosis	0.000313	0.00182	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Conjugated Estrogens—osteoporosis	0.00031	0.00181	CcSEcCtD
Acetylsalicylic acid—Urticaria—Ethinyl Estradiol—osteoporosis	0.00031	0.0018	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Calcitriol—osteoporosis	0.000309	0.0018	CcSEcCtD
Acetylsalicylic acid—Dizziness—Raloxifene—osteoporosis	0.000308	0.00179	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000307	0.00179	CcSEcCtD
Acetylsalicylic acid—Vomiting—Estropipate—osteoporosis	0.000306	0.00178	CcSEcCtD
Acetylsalicylic acid—Dizziness—Ibandronate—osteoporosis	0.000305	0.00178	CcSEcCtD
Acetylsalicylic acid—Rash—Estropipate—osteoporosis	0.000303	0.00177	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Estropipate—osteoporosis	0.000303	0.00176	CcSEcCtD
Acetylsalicylic acid—Urticaria—Risedronate—osteoporosis	0.000302	0.00176	CcSEcCtD
Acetylsalicylic acid—Vomiting—Alendronate—osteoporosis	0.000301	0.00175	CcSEcCtD
Acetylsalicylic acid—Rash—Alendronate—osteoporosis	0.000299	0.00174	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Alendronate—osteoporosis	0.000299	0.00174	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Pamidronate—osteoporosis	0.000298	0.00173	CcSEcCtD
Acetylsalicylic acid—Vomiting—Raloxifene—osteoporosis	0.000296	0.00173	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Zoledronate—osteoporosis	0.000294	0.00171	CcSEcCtD
Acetylsalicylic acid—ABCB1—uterus—osteoporosis	0.000294	0.00574	CbGeAlD
Acetylsalicylic acid—Rash—Raloxifene—osteoporosis	0.000294	0.00171	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Raloxifene—osteoporosis	0.000294	0.00171	CcSEcCtD
Acetylsalicylic acid—Somnolence—Zoledronate—osteoporosis	0.000294	0.00171	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ibandronate—osteoporosis	0.000293	0.00171	CcSEcCtD
Acetylsalicylic acid—Rash—Ibandronate—osteoporosis	0.000291	0.00169	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ibandronate—osteoporosis	0.000291	0.00169	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Zoledronate—osteoporosis	0.000291	0.00169	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000287	0.00167	CcSEcCtD
Acetylsalicylic acid—Vomiting—Calcitriol—osteoporosis	0.000287	0.00167	CcSEcCtD
Acetylsalicylic acid—Agitation—Estradiol—osteoporosis	0.000287	0.00167	CcSEcCtD
Acetylsalicylic acid—Nausea—Estropipate—osteoporosis	0.000286	0.00166	CcSEcCtD
Acetylsalicylic acid—Angioedema—Estradiol—osteoporosis	0.000285	0.00166	CcSEcCtD
Acetylsalicylic acid—Rash—Calcitriol—osteoporosis	0.000285	0.00166	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Calcitriol—osteoporosis	0.000285	0.00166	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000284	0.00165	CcSEcCtD
Acetylsalicylic acid—Somnolence—Conjugated Estrogens—osteoporosis	0.000283	0.00165	CcSEcCtD
Acetylsalicylic acid—Nausea—Alendronate—osteoporosis	0.000282	0.00164	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Risedronate—osteoporosis	0.00028	0.00163	CcSEcCtD
Acetylsalicylic acid—Vertigo—Estradiol—osteoporosis	0.00028	0.00163	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00028	0.00163	CcSEcCtD
Acetylsalicylic acid—Syncope—Estradiol—osteoporosis	0.00028	0.00163	CcSEcCtD
Acetylsalicylic acid—Nausea—Raloxifene—osteoporosis	0.000277	0.00161	CcSEcCtD
Acetylsalicylic acid—Pruritus—Ethinyl Estradiol—osteoporosis	0.000276	0.00161	CcSEcCtD
Acetylsalicylic acid—Nausea—Ibandronate—osteoporosis	0.000274	0.0016	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Estradiol—osteoporosis	0.000274	0.0016	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Zoledronate—osteoporosis	0.000272	0.00158	CcSEcCtD
Acetylsalicylic acid—Hypertension—Estradiol—osteoporosis	0.000269	0.00157	CcSEcCtD
Acetylsalicylic acid—Pruritus—Risedronate—osteoporosis	0.000269	0.00157	CcSEcCtD
Acetylsalicylic acid—Nausea—Calcitriol—osteoporosis	0.000268	0.00156	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000267	0.00155	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Pamidronate—osteoporosis	0.000266	0.00155	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Estradiol—osteoporosis	0.000266	0.00155	CcSEcCtD
Acetylsalicylic acid—Chest pain—Estradiol—osteoporosis	0.000266	0.00155	CcSEcCtD
Acetylsalicylic acid—Urticaria—Zoledronate—osteoporosis	0.000262	0.00153	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Risedronate—osteoporosis	0.00026	0.00151	CcSEcCtD
Acetylsalicylic acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.000258	0.0015	CcSEcCtD
Acetylsalicylic acid—Confusional state—Estradiol—osteoporosis	0.000257	0.00149	CcSEcCtD
Acetylsalicylic acid—Pruritus—Pamidronate—osteoporosis	0.000256	0.00149	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Estradiol—osteoporosis	0.000255	0.00148	CcSEcCtD
Acetylsalicylic acid—Urticaria—Conjugated Estrogens—osteoporosis	0.000253	0.00147	CcSEcCtD
Acetylsalicylic acid—Dizziness—Risedronate—osteoporosis	0.000252	0.00146	CcSEcCtD
Acetylsalicylic acid—Shock—Estradiol—osteoporosis	0.00025	0.00146	CcSEcCtD
Acetylsalicylic acid—ABCB1—bone marrow—osteoporosis	0.00025	0.00487	CbGeAlD
Acetylsalicylic acid—Tachycardia—Estradiol—osteoporosis	0.000248	0.00145	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.000248	0.00144	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Pamidronate—osteoporosis	0.000247	0.00144	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Estradiol—osteoporosis	0.000246	0.00143	CcSEcCtD
Acetylsalicylic acid—Rash—Ethinyl Estradiol—osteoporosis	0.000246	0.00143	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000246	0.00143	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Zoledronate—osteoporosis	0.000243	0.00142	CcSEcCtD
Acetylsalicylic acid—Vomiting—Risedronate—osteoporosis	0.000242	0.00141	CcSEcCtD
Acetylsalicylic acid—Rash—Risedronate—osteoporosis	0.00024	0.0014	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Risedronate—osteoporosis	0.00024	0.00139	CcSEcCtD
Acetylsalicylic acid—Dizziness—Pamidronate—osteoporosis	0.000239	0.00139	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000234	0.00136	CcSEcCtD
Acetylsalicylic acid—Pruritus—Zoledronate—osteoporosis	0.000234	0.00136	CcSEcCtD
Acetylsalicylic acid—Nausea—Ethinyl Estradiol—osteoporosis	0.000232	0.00135	CcSEcCtD
Acetylsalicylic acid—Vomiting—Pamidronate—osteoporosis	0.00023	0.00134	CcSEcCtD
Acetylsalicylic acid—Rash—Pamidronate—osteoporosis	0.000228	0.00133	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Pamidronate—osteoporosis	0.000228	0.00133	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Estradiol—osteoporosis	0.000227	0.00132	CcSEcCtD
Acetylsalicylic acid—Somnolence—Estradiol—osteoporosis	0.000226	0.00132	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Zoledronate—osteoporosis	0.000226	0.00132	CcSEcCtD
Acetylsalicylic acid—Nausea—Risedronate—osteoporosis	0.000226	0.00132	CcSEcCtD
Acetylsalicylic acid—Pruritus—Conjugated Estrogens—osteoporosis	0.000225	0.00131	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Estradiol—osteoporosis	0.000224	0.0013	CcSEcCtD
Acetylsalicylic acid—Dizziness—Zoledronate—osteoporosis	0.000218	0.00127	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000218	0.00127	CcSEcCtD
Acetylsalicylic acid—Nausea—Pamidronate—osteoporosis	0.000215	0.00125	CcSEcCtD
Acetylsalicylic acid—Dizziness—Conjugated Estrogens—osteoporosis	0.00021	0.00122	CcSEcCtD
Acetylsalicylic acid—Vomiting—Zoledronate—osteoporosis	0.00021	0.00122	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Estradiol—osteoporosis	0.00021	0.00122	CcSEcCtD
Acetylsalicylic acid—Rash—Zoledronate—osteoporosis	0.000208	0.00121	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Zoledronate—osteoporosis	0.000208	0.00121	CcSEcCtD
Acetylsalicylic acid—Vomiting—Conjugated Estrogens—osteoporosis	0.000202	0.00118	CcSEcCtD
Acetylsalicylic acid—Urticaria—Estradiol—osteoporosis	0.000202	0.00118	CcSEcCtD
Acetylsalicylic acid—Rash—Conjugated Estrogens—osteoporosis	0.000201	0.00117	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Conjugated Estrogens—osteoporosis	0.0002	0.00117	CcSEcCtD
Acetylsalicylic acid—Nausea—Zoledronate—osteoporosis	0.000196	0.00114	CcSEcCtD
Acetylsalicylic acid—Nausea—Conjugated Estrogens—osteoporosis	0.000189	0.0011	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Estradiol—osteoporosis	0.000188	0.00109	CcSEcCtD
Acetylsalicylic acid—Pruritus—Estradiol—osteoporosis	0.00018	0.00105	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Estradiol—osteoporosis	0.000174	0.00101	CcSEcCtD
Acetylsalicylic acid—Dizziness—Estradiol—osteoporosis	0.000168	0.00098	CcSEcCtD
Acetylsalicylic acid—Vomiting—Estradiol—osteoporosis	0.000162	0.000942	CcSEcCtD
Acetylsalicylic acid—Rash—Estradiol—osteoporosis	0.00016	0.000934	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Estradiol—osteoporosis	0.00016	0.000933	CcSEcCtD
Acetylsalicylic acid—Nausea—Estradiol—osteoporosis	0.000151	0.00088	CcSEcCtD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTH—osteoporosis	1.91e-05	8.8e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—LEP—osteoporosis	1.9e-05	8.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GAPDH—osteoporosis	1.89e-05	8.74e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—osteoporosis	1.89e-05	8.71e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6R—osteoporosis	1.88e-05	8.7e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—LEP—osteoporosis	1.88e-05	8.69e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—OXCT1—osteoporosis	1.88e-05	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CA2—osteoporosis	1.88e-05	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—osteoporosis	1.88e-05	8.67e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RAP1A—osteoporosis	1.87e-05	8.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CA2—osteoporosis	1.87e-05	8.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—OXCT1—osteoporosis	1.87e-05	8.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CNR2—osteoporosis	1.86e-05	8.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—RAP1A—osteoporosis	1.84e-05	8.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MGLL—osteoporosis	1.83e-05	8.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—P4HB—osteoporosis	1.83e-05	8.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NFATC1—osteoporosis	1.83e-05	8.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MGLL—osteoporosis	1.82e-05	8.41e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ESR1—osteoporosis	1.82e-05	8.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DKK1—osteoporosis	1.81e-05	8.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP27A1—osteoporosis	1.8e-05	8.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ATIC—osteoporosis	1.8e-05	8.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PNP—osteoporosis	1.8e-05	8.31e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ESR1—osteoporosis	1.8e-05	8.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—GAPDH—osteoporosis	1.79e-05	8.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.77e-05	8.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.76e-05	8.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ACP5—osteoporosis	1.75e-05	8.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—WNT1—osteoporosis	1.75e-05	8.06e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IRS2—osteoporosis	1.74e-05	8.03e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IRS2—osteoporosis	1.74e-05	8.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.73e-05	7.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.73e-05	7.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.72e-05	7.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NFATC1—osteoporosis	1.7e-05	7.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—LEP—osteoporosis	1.7e-05	7.86e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—LEP—osteoporosis	1.7e-05	7.86e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IRS1—osteoporosis	1.7e-05	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGA—osteoporosis	1.7e-05	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—DKK1—osteoporosis	1.69e-05	7.81e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—osteoporosis	1.69e-05	7.79e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MYC—osteoporosis	1.69e-05	7.79e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—osteoporosis	1.68e-05	7.77e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IRS1—osteoporosis	1.68e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—osteoporosis	1.68e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—OXCT1—osteoporosis	1.68e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CA2—osteoporosis	1.68e-05	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.65e-05	7.59e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—OXCT1—osteoporosis	1.64e-05	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CA2—osteoporosis	1.64e-05	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—POMC—osteoporosis	1.64e-05	7.55e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MGLL—osteoporosis	1.63e-05	7.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—WNT1—osteoporosis	1.63e-05	7.52e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TPI1—osteoporosis	1.63e-05	7.51e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ESR1—osteoporosis	1.63e-05	7.5e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ESR1—osteoporosis	1.63e-05	7.5e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—POMC—osteoporosis	1.62e-05	7.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.61e-05	7.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MGLL—osteoporosis	1.6e-05	7.37e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6R—osteoporosis	1.6e-05	7.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGA—osteoporosis	1.58e-05	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTHLH—osteoporosis	1.58e-05	7.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BMP2—osteoporosis	1.58e-05	7.29e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6R—osteoporosis	1.58e-05	7.28e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IGF1—osteoporosis	1.57e-05	7.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—IDH2—osteoporosis	1.56e-05	7.19e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF1—osteoporosis	1.56e-05	7.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—IDH2—osteoporosis	1.55e-05	7.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGB—osteoporosis	1.54e-05	7.13e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.54e-05	7.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AGER—osteoporosis	1.53e-05	7.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—P4HB—osteoporosis	1.53e-05	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CA2—osteoporosis	1.53e-05	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—OXCT1—osteoporosis	1.53e-05	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ADCY5—osteoporosis	1.53e-05	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IRS1—osteoporosis	1.52e-05	7.01e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IRS1—osteoporosis	1.52e-05	7.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GAPDH—osteoporosis	1.5e-05	6.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—osteoporosis	1.5e-05	6.91e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PSMA2—osteoporosis	1.49e-05	6.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PSMA5—osteoporosis	1.49e-05	6.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MGLL—osteoporosis	1.49e-05	6.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ENO1—osteoporosis	1.49e-05	6.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—osteoporosis	1.47e-05	6.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PSMA2—osteoporosis	1.47e-05	6.78e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PSMA5—osteoporosis	1.47e-05	6.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.46e-05	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—RAP1A—osteoporosis	1.46e-05	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—POMC—osteoporosis	1.46e-05	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—POMC—osteoporosis	1.46e-05	6.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP27A1—osteoporosis	1.46e-05	6.72e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6R—osteoporosis	1.43e-05	6.59e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6R—osteoporosis	1.43e-05	6.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ACP5—osteoporosis	1.42e-05	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ACP5—osteoporosis	1.42e-05	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ENO1—osteoporosis	1.41e-05	6.52e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF1—osteoporosis	1.41e-05	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF1—osteoporosis	1.41e-05	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.41e-05	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.41e-05	6.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.4e-05	6.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PSMA2—osteoporosis	1.39e-05	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PSMA5—osteoporosis	1.39e-05	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—IDH2—osteoporosis	1.39e-05	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CALCA—osteoporosis	1.39e-05	6.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—IDH2—osteoporosis	1.36e-05	6.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRS2—osteoporosis	1.34e-05	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.33e-05	6.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TPI1—osteoporosis	1.32e-05	6.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TPI1—osteoporosis	1.32e-05	6.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.31e-05	6.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CALCA—osteoporosis	1.3e-05	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.28e-05	5.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP27A1—osteoporosis	1.28e-05	5.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ACP5—osteoporosis	1.27e-05	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.27e-05	5.86e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—osteoporosis	1.27e-05	5.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—IDH2—osteoporosis	1.27e-05	5.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KL—osteoporosis	1.26e-05	5.83e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.26e-05	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.25e-05	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.25e-05	5.77e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—P4HB—osteoporosis	1.25e-05	5.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ACP5—osteoporosis	1.24e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—P4HB—osteoporosis	1.24e-05	5.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GAPDH—osteoporosis	1.22e-05	5.64e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GAPDH—osteoporosis	1.22e-05	5.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.19e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP19A1—osteoporosis	1.19e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RAP1A—osteoporosis	1.19e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RAP1A—osteoporosis	1.18e-05	5.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ENO1—osteoporosis	1.18e-05	5.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TPI1—osteoporosis	1.18e-05	5.46e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MYC—osteoporosis	1.18e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—osteoporosis	1.18e-05	5.44e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KL—osteoporosis	1.18e-05	5.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.17e-05	5.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRS1—osteoporosis	1.17e-05	5.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.17e-05	5.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PSMA2—osteoporosis	1.17e-05	5.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PSMA5—osteoporosis	1.17e-05	5.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ACP5—osteoporosis	1.16e-05	5.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TPI1—osteoporosis	1.15e-05	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.14e-05	5.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—P4HB—osteoporosis	1.11e-05	5.13e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—osteoporosis	1.1e-05	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6R—osteoporosis	1.1e-05	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GAPDH—osteoporosis	1.09e-05	5.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF1—osteoporosis	1.09e-05	5.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—P4HB—osteoporosis	1.08e-05	5.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TPI1—osteoporosis	1.08e-05	4.98e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—osteoporosis	1.08e-05	4.97e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—osteoporosis	1.08e-05	4.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GAPDH—osteoporosis	1.06e-05	4.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RAP1A—osteoporosis	1.06e-05	4.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.04e-05	4.79e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RAP1A—osteoporosis	1.04e-05	4.79e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.03e-05	4.77e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—P4HB—osteoporosis	1.01e-05	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GAPDH—osteoporosis	9.95e-06	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADCY5—osteoporosis	9.89e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—osteoporosis	9.83e-06	4.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ADCY5—osteoporosis	9.73e-06	4.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GPX1—osteoporosis	9.7e-06	4.48e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RAP1A—osteoporosis	9.69e-06	4.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ENO1—osteoporosis	9.62e-06	4.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ENO1—osteoporosis	9.57e-06	4.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SPP1—osteoporosis	9.57e-06	4.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PSMA2—osteoporosis	9.48e-06	4.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PSMA5—osteoporosis	9.48e-06	4.38e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—osteoporosis	9.46e-06	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP19A1—osteoporosis	9.45e-06	4.36e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—osteoporosis	9.43e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PSMA5—osteoporosis	9.43e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PSMA2—osteoporosis	9.43e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—osteoporosis	9.35e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—osteoporosis	9.32e-06	4.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.27e-06	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ADCY5—osteoporosis	9.22e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MTHFR—osteoporosis	8.95e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—osteoporosis	8.88e-06	4.1e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IRS2—osteoporosis	8.65e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ENO1—osteoporosis	8.59e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTHFR—osteoporosis	8.48e-06	3.92e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—LEP—osteoporosis	8.47e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PSMA2—osteoporosis	8.46e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PSMA5—osteoporosis	8.46e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—osteoporosis	8.45e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—osteoporosis	8.45e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.45e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—osteoporosis	8.43e-06	3.89e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—osteoporosis	8.43e-06	3.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—osteoporosis	8.39e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ENO1—osteoporosis	8.38e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—osteoporosis	8.35e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PSMA2—osteoporosis	8.26e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PSMA5—osteoporosis	8.26e-06	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ESR1—osteoporosis	8.08e-06	3.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS2—osteoporosis	8.07e-06	3.73e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ENO1—osteoporosis	7.83e-06	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ADCY5—osteoporosis	7.72e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PSMA5—osteoporosis	7.72e-06	3.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PSMA2—osteoporosis	7.72e-06	3.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GPX1—osteoporosis	7.7e-06	3.55e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP19A1—osteoporosis	7.69e-06	3.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP19A1—osteoporosis	7.65e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IRS1—osteoporosis	7.55e-06	3.49e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—POMC—osteoporosis	7.27e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—POMC—osteoporosis	7.16e-06	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—osteoporosis	7.11e-06	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—osteoporosis	7.1e-06	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6R—osteoporosis	7.09e-06	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS1—osteoporosis	7.04e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—osteoporosis	7.03e-06	3.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—osteoporosis	6.99e-06	3.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP19A1—osteoporosis	6.87e-06	3.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP19A1—osteoporosis	6.7e-06	3.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6R—osteoporosis	6.62e-06	3.06e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—osteoporosis	6.54e-06	3.02e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—osteoporosis	6.35e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—osteoporosis	6.35e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ADCY5—osteoporosis	6.28e-06	2.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPX1—osteoporosis	6.26e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.26e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ADCY5—osteoporosis	6.25e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPX1—osteoporosis	6.23e-06	2.88e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—osteoporosis	5.78e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—osteoporosis	5.75e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—POMC—osteoporosis	5.68e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ADCY5—osteoporosis	5.61e-06	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPX1—osteoporosis	5.59e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ADCY5—osteoporosis	5.48e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPX1—osteoporosis	5.46e-06	2.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—osteoporosis	5.16e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ADCY5—osteoporosis	5.12e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPX1—osteoporosis	5.1e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—osteoporosis	5.04e-06	2.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—osteoporosis	4.89e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—osteoporosis	4.7e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—POMC—osteoporosis	4.62e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—POMC—osteoporosis	4.6e-06	2.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—osteoporosis	4.2e-06	1.94e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—osteoporosis	4.19e-06	1.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—POMC—osteoporosis	4.13e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—POMC—osteoporosis	4.03e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—osteoporosis	3.92e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—osteoporosis	3.91e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—POMC—osteoporosis	3.76e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—osteoporosis	3.16e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—osteoporosis	2.95e-06	1.36e-05	CbGpPWpGaD
